Published • loading... • Updated
ADMA Biologics Inc (ADMA) Stock Analysis: High Potential Upside Amid Robust Growth Trends
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ADMA Biologics Inc (ADMA) Stock Analysis: High Potential Upside Amid Robust Growth Trends
ADMA Biologics Inc (NASDAQ: ADMA), a pioneering player in the biotechnology sector, is poised for substantial growth, offering a remarkable potential upside of 96.65%. This healthcare company, with a market capitalization of $2.07 billion, is strategically positioned in the biopharmaceutical industry, focusing on the development and distribution of plasma-derived therapeutics. Headquartered in Ramsey, New Jersey, ADMA Biologics has established a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
